StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.48−0.04 (-2.63%)

Close on Nov 20, 2026Market cap $70.14MP/E –Yield –

Zhengye Biotechnology net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -CN¥69.78M, down 717.0% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CN¥69.78M-717.0%
FY2024Dec 31, 2024CN¥11.31M-64.0%
FY2023Dec 31, 2023CN¥31.46M-32.7%
FY2022Dec 31, 2022CN¥46.74M–

More Zhengye Biotechnology figures

See a number that looks wrong?